PK-PD Modeling & Simulation Study
- Program Objective
- To facilitate entry into clinical trials and improve the success rate of drug development, this program provides science-based PK-PD modeling and simulation analyses through partnerships with clinical pharmacology experts. The goal is to support optimized nonclinical and clinical development strategies.
- Program Details
- Program Period: Mar-Dec, 2026 (3-5 months/project)
② Estimating optimal dose and dosing regimen for early clinical trials
- Contact
R&D Enabling & Strategy Team: rnd_project@kddf.org